Literature DB >> 20381588

Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.

K L Eagleson1, M C Gravielle, L J Schlueter McFadyen-Ketchum, S J Russek, D H Farb, P Levitt.   

Abstract

Disruption of the GABAergic system has been implicated in multiple developmental disorders, including epilepsy, autism spectrum disorder and schizophrenia. The human gene encoding uPAR (PLAUR) has been shown recently to be associated with the risk of autism. The uPAR(-/-) mouse exhibits a regionally-selective reduction in GABAergic interneurons in frontal and parietal regions of the cerebral cortex as well as in the CA1 and dentate gyrus subfields of the hippocampus. Behaviorally, these mice exhibit increased sensitivity to pharmacologically-induced seizures, heightened anxiety, and atypical social behavior. Here, we explore potential alterations in GABAergic circuitry that may occur in the context of altered interneuron development. Analysis of gene expression for 13 GABA(A) receptor subunits using quantitative real-time polymerase chain reaction (PCR) indicates seven subunit mRNAs (alpha(1), alpha(2), alpha(3), beta(2), beta(3), gamma(2S) and gamma(2L)) of interest. Semi-quantitative in situ hybridization analysis focusing on these subunit mRNAs reveals a complex pattern of potential gene regulatory adaptations. The levels of alpha(2) subunit mRNAs increase in frontal cortex, CA1 and CA3, while those of alpha3 decrease in frontal cortex and CA1. In contrast, alpha(1) subunit mRNAs are unaltered in any region examined. beta(2) subunit mRNAs are increased in frontal cortex whereas beta(3) subunit mRNAs are decreased in parietal cortex. Finally, gamma(2S) subunit mRNAs are increased in parietal cortex while gamma(2L) subunit mRNAs are increased in the dentate gyrus, potentially altering the gamma(2S):gamma(2L) ratio in these two regions. For all subunits, no changes were observed in forebrain regions where GABAergic interneuron numbers are normal. We propose that disrupted differentiation of GABAergic neurons specifically in frontal and parietal cortices leads to regionally-selective alterations in local circuitry and subsequent adaptive changes in receptor subunit composition. Future electrophysiological studies will be useful in determining how alterations in network activity in the cortex and hippocampus relate to the observed behavioral phenotype. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381588      PMCID: PMC2880553          DOI: 10.1016/j.neuroscience.2010.03.066

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  85 in total

1.  Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.

Authors:  Jamie L Maguire; Brandon M Stell; Mahsan Rafizadeh; Istvan Mody
Journal:  Nat Neurosci       Date:  2005-05-15       Impact factor: 24.884

Review 2.  GABA(A) receptor diversity and pharmacology.

Authors:  H Möhler
Journal:  Cell Tissue Res       Date:  2006-08-26       Impact factor: 5.249

3.  GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia.

Authors:  G P Reynolds; C L Beasley
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

4.  Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus.

Authors:  T Nishimura; C Schwarzer; E Gasser; N Kato; A Vezzani; G Sperk
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 5.  uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.

Authors:  Bernd R Binder; Judit Mihaly; Gerald W Prager
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

6.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

7.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

8.  Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study.

Authors:  J M Fritschy; J Paysan; A Enna; H Mohler
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

9.  Variations in maternal care alter GABA(A) receptor subunit expression in brain regions associated with fear.

Authors:  Christian Caldji; Josie Diorio; Michael J Meaney
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

10.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

Authors:  S Akbarian; M M Huntsman; J J Kim; A Tafazzoli; S G Potkin; W E Bunney; E G Jones
Journal:  Cereb Cortex       Date:  1995 Nov-Dec       Impact factor: 5.357

View more
  8 in total

1.  GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Authors:  J L Silverman; M C Pride; J E Hayes; K R Puhger; H M Butler-Struben; S Baker; J N Crawley
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

Review 2.  A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors.

Authors:  Jing-Qiong Kang; Gregory Barnes
Journal:  J Autism Dev Disord       Date:  2013-01

Review 3.  Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.

Authors:  Christina Gross; Elizabeth M Berry-Kravis; Gary J Bassell
Journal:  Neuropsychopharmacology       Date:  2011-07-27       Impact factor: 7.853

4.  The autism risk genes MET and PLAUR differentially impact cortical development.

Authors:  Kathie L Eagleson; Daniel B Campbell; Barbara L Thompson; Mica Y Bergman; Pat Levitt
Journal:  Autism Res       Date:  2010-12-03       Impact factor: 5.216

5.  The co-morbidity burden of children and young adults with autism spectrum disorders.

Authors:  Isaac S Kohane; Andrew McMurry; Griffin Weber; Douglas MacFadden; Leonard Rappaport; Louis Kunkel; Jonathan Bickel; Nich Wattanasin; Sarah Spence; Shawn Murphy; Susanne Churchill
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

6.  Probiotic Ameliorating Effects of Altered GABA/Glutamate Signaling in a Rodent Model of Autism.

Authors:  Rawan M Bin-Khattaf; Mona A Alonazi; Abeer M Al-Dbass; Ahmad T Almnaizel; Hisham S Aloudah; Dina A Soliman; Afaf K El-Ansary
Journal:  Metabolites       Date:  2022-08-04

Review 7.  GABA system dysfunction in autism and related disorders: from synapse to symptoms.

Authors:  Suzanne Coghlan; Jamie Horder; Becky Inkster; M Andreina Mendez; Declan G Murphy; David J Nutt
Journal:  Neurosci Biobehav Rev       Date:  2012-07-25       Impact factor: 8.989

8.  Modulatory effects of inhibition on persistent activity in a cortical microcircuit model.

Authors:  Xanthippi Konstantoudaki; Athanasia Papoutsi; Kleanthi Chalkiadaki; Panayiota Poirazi; Kyriaki Sidiropoulou
Journal:  Front Neural Circuits       Date:  2014-01-31       Impact factor: 3.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.